Seminars in Hematology
Volume 42, Issue 1 , Pages 1-4 , January 2005

von Willebrand factor: A prima ballerina on two different stages

  • Pier M. Mannucci, MD (Guest Editor)

      Affiliations

    • IRCCS Maggiore Hospital and University of Milan, Milan, Italy

References 

  1. von Willebrand EA . Hereditaz pseudohemofili . Finska Lakarsalls Kapets Handl . 1926;67:7–112
  2. Zimmerman TS , Ratnoff OD , Powell EA . Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand disease, with observation on combined deficiencies of circulation anticoagulant against antihemophilia factor . J Clin Invest . 1976;50:244–254
  3. Ginsburg D , Handin RI , Bonthron DT , Donlon TA , Bruns GA , Latt SA , et al.   Human von Willebrand factor (vWF) (Isolation of complementary DNA (cDNA) clones and chromosomal localization) . Science . 1985;228:1401–1406
  4. Mendolicchio GL , Ruggeri ZM . New perspectives on von Willebrand factor functions in hemostasis and thrombosis . Semin Hematol . 2005;42:5–14
  5. Ruggeri ZM . Type IIB von Willebrand disease (A paradox explains how von Willebrand factor works) . J Thromb Haemost . 2004;2:2–6
  6. Dumas JJ , Kumar R , McDonagh T , Sullivan F , Stahl ML , Somers WS , et al.   Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations . J Biol Chem . 2004;279:23327–23334
  7. Celikel R , Ruggeri ZM , Varughese KI . von Willebrand factor conformation and adhesive function is modulated by an internalized water molecule . Nat Struct Biol . 2000;7:881–884
  8. Howard MA , Firkin BG . Ristocetin—A new tool in the investigation of platelet aggregation . Thromb Diath Haemorrh . 1971;26:362–369
  9. Weiss HJ , Hoyer LW , Rickles FR , Varma A , Rogers J . Quantitative assay of a plasma factor deficient in von Willebrand’s disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content . J Clin Invest . 1973;52:2708–2716
  10. Favaloro EJ , Grispo L , Exner T , Koutts J . Development of a simple collagen based ELISA assay aids in the diagnosis of, and permits sensitive discrimination between type I and type II, von Willebrand’s disease . Blood Coagul Fibrinolysis . 1991;2:285–291
  11. Fressinaud E , Veyradier A , Truchaud F , Martin I , Boyer-Neumann C , Trossaert M , et al.   Screening for von Willebrand disease with a new analyzer using high shear stress (A study of 60 cases) . Blood . 1998;91:1325–1331
  12. Ruggeri ZM , Zimmerman TS . Variant von Willebrand’s disease (Characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets) . J Clin Invest . 1980;65:1318–1325
  13. Ruggeri ZM , Zimmerman TS . The complex multimeric composition of factor VIII/von Willebrand factor . Blood . 1981;57:1140–1143
  14. Sadler JE  Subcommittee on von Willebrand Factor of the Scientific  Standardization Committee of the International Society on Thrombosis and Haemostasis . A revised classification of von Willebrand disease . Thromb Haemost . 1994;71:520–525
  15. Schneppenheim R , Budde U . Phenotypic and genotypic diagnosis of von Willebrand disease (A 2004 update) . Semin Hematol . 2005;42:15–28
  16. Zhang ZP , Falk G , Blomback M , Egberg N , Anvret M . A single cytosine deletion in exon 18 of the von Willebrand factor gene is the most common mutation in Swedish VWD type III patients . Hum Mol Genet . 1992;1:767–768
  17. Schneppenheim R , Krey S , Bergmann F , Bock D , Budde U , Lange M , et al.   Genetic heterogeneity of severe von Willebrand disease type III in the German population . Hum Genet . 1994;94:640–652
  18. Silwer J . von Willebrand’s disease in Sweden . Acta Paediatr Scand . 1973;238(suppl):1–159
  19. Lak M , Peyvandi F , Mannucci PM . Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease . Br J Haematol . 2000;111:1236–1239
  20. Foster PA  Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH . The reproductive health of women with von Willebrand Disease unresponsive to DDAVP (Results of an international survey) . Thromb Haemost . 1995;74:784–790
  21. Lee C , Kadir R . Von Willebrand disease and women’s health . Semin Hematol . 2005;42:42–48
  22. Mannucci PM . Treatment of von Willebrand’s disease . N Engl J Med . 2004;351:683–694
  23. Rodeghiero F , Castaman G . Treatment of von Willebrand disease . Semin Hematol . 2005;42: xx-xx
  24. Federici AB , Mazurier C , Berntorp E , Lee CA , Scharrer I , Goudemand J , et al.   Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease (Results of a multicenter European study) . Blood . 2002;103: 203a2-2038
  25. Mannucci PM . Use of DDAVP in pregnancy . Haemophilia . 2004;10(suppl 3):143; (abstr)
  26. Srivastava A . Von Willebrand disease in the developing world . Semin Hematol . 2005;42:36–41
  27. Nichols TC , Bellinger DA , Johnson TA , Lamb MA , Griggs TR . von Willebrand’s disease prevents occlusive thrombosis in stenosed and injured porcine coronary arteries . Circ Res . 1986;59:15–26
  28. Nichols TC , Bellinger DA , Tate DA , Reddick RL , Read MS , Koch GG , et al.   von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand’s disease pigs with diet-induced hypercholesterolemia and atherosclerosis . Arteriosclerosis . 1990;10:449–461
  29. Nichols TC , Bellinger DA , Reddick RL , Smith SV , Koch GG , Davis K , et al.   The roles of von Willebrand factor and factor VIII in arterial thrombosis (Studies in canine von Willebrand disease and hemophilia A) . Blood . 1993;81:2644–2651
  30. Jansson JH , Nilsson TK , Johnson O . von Willebrand factor in plasma (A novel risk factor for recurrent myocardial infarction and death) . Br Heart J . 1991;66:351–355
  31. Rumley A , Lowe GD , Sweetnam PM , Yarnell JW , Ford RP . Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study . Br J Haematol . 1999;105:110–116
  32. Thompson SG , Kienast J , Pyke SD , Haverkate F , van de Loo JC  European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group . Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris . N Engl J Med . 1995;332:635–641
  33. Jager A , van Hinsbergh VW , Kostense PJ , Emeis JJ , Yudkin JS , Nijpels G , et al.   von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects (The Hoorn Study) . Arterioscler Thromb Vasc Biol . 1999;19:3071–3078
  34. Martinelli I . von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis . Semin Hematol . 2005;42:49–55
  35. Moake JL . Defective processing of unusually large von Willebrand factor multimers and thrombotic thrombocytopenic purpura . J Thromb Haemost . 2004;2:1515–1521
  36. Furlan M . Proteolytic cleavage of von Willebrand factor by ADAMTS-13 prevents uninvited clumping of blood platelets . J Thromb Haemost . 2004;2:1505–1509
  37. Tsai HM . A journey from sickle cell anemia to ADAMTS13 . J Thromb Haemost . 2004;2:1510–1514
  38. Soejima K , Nakagaki T . Interplay between ADAMTS-13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies . Semin Hematol . 2005;42:56–62
  39. Dong JF , Whitelock J , Bernardo A , Ball C , Cruz MA . Variations among normal individuals in the cleavage of endothelial-derived ultra-large von Willebrand factor under flow . J Thromb Haemost . 2004;2:1460–1466
  40. Studt JD , Bohm M , Budde U , Girma JP , Varadi K , Lammle B . Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma (A multicenter comparison of different assay methods) . J Thromb Haemost . 2003;1:1882–1887
  41. Tripodi A , Chantarangkul V , Bohm M , Budde U , Dong JF , Friedman KD , et al.   Measurement of von Willebrand factor cleaving protease (ADAMTS-13) (Results of an international collaborative study involving 11 methods testing the same set of coded plasmas) . J Thromb Haemost . 2004;2:1601–1609

PII: S0037-1963(04)00254-9

doi: 10.1053/j.seminhematol.2004.11.001

Seminars in Hematology
Volume 42, Issue 1 , Pages 1-4 , January 2005

Article Tools